Related references
Note: Only part of the references are listed.Identification of a serotonin/glutamate receptor complex implicated in psychosis
Javier Gonzalez-Maeso et al.
NATURE (2008)
Conformational cross-talk between α2A-adrenergic and μ-opioid receptors controls cell signaling
Jean-Pierre Vilardaga et al.
NATURE CHEMICAL BIOLOGY (2008)
Versatility of GPCR recognition by drugs: from biological implications to therapeutic relevance
Barbara Bosier et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
The evasive nature of drug efficacy:: implications for drug discovery
Segolene Galandrin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Protean agonism at the dopamine D2 receptor:: (S)-3-(3-hydroxyphenyl)-N-propylpiperidine is an agonist for activation of Go1 but an antagonist/inverse agonist for Gi1, Gi2, and Gi3
J. Robert Lane et al.
MOLECULAR PHARMACOLOGY (2007)
Extracellular signal-regulated kinase 1/2-mediated transcriptional regulation of G-protein-coupled receptor kinase 3 expression in neuronal cells
Samina Salim et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
The α1b-adrenoceptor exists as a higher-order oligomer:: Effective oligomerization is required for receptor maturation, surface delivery, and function
Juan F. Lopez-Gimenez et al.
MOLECULAR PHARMACOLOGY (2007)
An essential role for constitutive endocytosis, but not activity, in the axonal targeting of the CB1 cannabinoid receptor
Neil A. McDonald et al.
MOLECULAR PHARMACOLOGY (2007)
The role of diacylglycerol lipase in constitutive and angiotensin AT1 receptor-stimulated cannabinoid CB1 receptor activity
Gabor Turu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
G protein-coupled receptor dimerisation: Molecular basis and relevance to function
Graeme Milligan
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Inverse agonism: from curiosity to accepted dogma, but is it clinically relevant?
Sergio Parra et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Opioid and cannabinoid receptors: friends with benefits or just close friends?
MacDonald J. Christie
BRITISH JOURNAL OF PHARMACOLOGY (2006)
μ opioid and CB1 cannabinoid receptor interactions:: reciprocal inhibition of receptor signaling and neuritogenesis
Carl Rios et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function
James Ellis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mu opioid receptor activation of ERK1/2 is GRK3 and arrestin dependent in striatal neurons
Tara A. Macey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse
Thora K. Bjarnadottir et al.
GENOMICS (2006)
Interactions between CB1 cannabinoid and μ opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core
A. N. M. Schoffelmeer et al.
NEUROPHARMACOLOGY (2006)
Up-regulation of the angiotensin II type 1 receptor by the MAS proto-oncogene is due to constitutive activation of Gq/G11 by MAS
Meritxell Canals et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Distinct β-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation
D Gesty-Palmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors
C Leterrier et al.
JOURNAL OF NEUROSCIENCE (2006)
Interactions between the Mas-related receptors MrgD and MrgE alter signalling and trafficking of MrgD
S Milasta et al.
MOLECULAR PHARMACOLOGY (2006)
Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor 'silent antagonist'
A Gardner et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
G-protein-coupled receptor heterodimers: pharmacology, function and relevance to drug discovery
Graeme Milligan
DRUG DISCOVERY TODAY (2006)
Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems
M Solinas et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: A mechanism for receptor cross-talk?
CS Kearn et al.
MOLECULAR PHARMACOLOGY (2005)
Inverse agonism and neutral antagonism at cannabinoid CBI receptors
RG Pertwee
LIFE SCIENCES (2005)
Differential kinetic and spatial patterns of β-arrestin and G protein-mediated ERK activation by the angiotensin II receptor
SK Ahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Efficacy as a vector: the relative prevalence and paucity of inverse agonism
T Kenakin
MOLECULAR PHARMACOLOGY (2004)
Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens
VM Pickel et al.
NEUROSCIENCE (2004)
Opioid receptors
M Waldhoer et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
Involvement of the Carboxyl Terminus of the Third Intracellular Loop of the Cannabinoid CB1 Receptor in Constitutive Activation of Gs
Vasiliki Abadji et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Hypersensitization of the orexin 1 receptor by the CB1 receptor -: Evidence for cross-talk blocked by the specific CB1 antagonist, SR141716
S Hilairet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Endocytosis of the viral chemokine receptor US28 does not require beta-arrestins but is dependent on the clathrin-mediated pathway
A Fraile-Ramos et al.
TRAFFIC (2003)
Principles:: Extending the utility of [35S]GTPγS binding assays
G Milligan
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective
G Milligan
MOLECULAR PHARMACOLOGY (2003)
G protein-coupled receptor signalling and cross-talk - Achieving rapidity and specificity
EM Hur et al.
CELLULAR SIGNALLING (2002)
CB1-cannabinoid and μ-opioid receptor co-localization on postsynaptic target in the rat dorsal horn
C Salio et al.
NEUROREPORT (2001)
New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades
KL Pierce et al.
ONCOGENE (2001)
Virally encoded 7TM receptors
MM Rosenkilde et al.
ONCOGENE (2001)
Share Paper
